Trials / Completed
CompletedNCT02838680
Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- HLT Inc. · Industry
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and performance of the HLT System in patients with severe aortic stenosis who present at high risk for aortic valve replacement surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HLT Transcatheter Aortic Valve System | Transcatheter aortic valve replacement with HLT Transcatheter Aortic Valve System |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2018-04-09
- Completion
- 2022-10-31
- First posted
- 2016-07-20
- Last updated
- 2023-05-31
Locations
2 sites across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02838680. Inclusion in this directory is not an endorsement.